instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia parainfluenzae viral'. | Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
BACKGROUND
The anti-SLAMF7 monoclonal antibody, elotuzumab (elo), plus lenalidomide (len) and dexamethasone (dex) is approved for... | ACYCLOVIR, DEXAMETHASONE, ELOTUZUMAB, POMALIDOMIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 32683487 | 19,054,245 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia pneumococcal'. | Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
BACKGROUND
The anti-SLAMF7 monoclonal antibody, elotuzumab (elo), plus lenalidomide (len) and dexamethasone (dex) is approved for... | ACYCLOVIR, DEXAMETHASONE, ELOTUZUMAB, POMALIDOMIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 32683487 | 19,057,523 | 2021-01 |
What was the administration route of drug 'ELOTUZUMAB'? | Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
BACKGROUND
The anti-SLAMF7 monoclonal antibody, elotuzumab (elo), plus lenalidomide (len) and dexamethasone (dex) is approved for... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32683487 | 19,057,439 | 2021-01 |
What was the administration route of drug 'POMALIDOMIDE'? | Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
BACKGROUND
The anti-SLAMF7 monoclonal antibody, elotuzumab (elo), plus lenalidomide (len) and dexamethasone (dex) is approved for... | Oral | DrugAdministrationRoute | CC BY | 32683487 | 19,057,439 | 2021-01 |
What was the dosage of drug 'ACYCLOVIR'? | Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
BACKGROUND
The anti-SLAMF7 monoclonal antibody, elotuzumab (elo), plus lenalidomide (len) and dexamethasone (dex) is approved for... | ADMINISTERED THROUGHOUT THE TREATMENT PERIOD | DrugDosageText | CC BY | 32683487 | 19,057,439 | 2021-01 |
What was the dosage of drug 'ELOTUZUMAB'? | Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
BACKGROUND
The anti-SLAMF7 monoclonal antibody, elotuzumab (elo), plus lenalidomide (len) and dexamethasone (dex) is approved for... | ON DAYS 1, 8, 15 AND 22 OF A 28?DAY CYCLE IN CYCLES 1 AND 2 AND ON DAYS 1 AND 15 IN THE SUBSEQUEN... | DrugDosageText | CC BY | 32683487 | 19,057,439 | 2021-01 |
What was the dosage of drug 'POMALIDOMIDE'? | Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
BACKGROUND
The anti-SLAMF7 monoclonal antibody, elotuzumab (elo), plus lenalidomide (len) and dexamethasone (dex) is approved for... | ON DAYS 1 THROUGH 21 OF EACH CYCLE | DrugDosageText | CC BY | 32683487 | 19,057,439 | 2021-01 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
BACKGROUND
The anti-SLAMF7 monoclonal antibody, elotuzumab (elo), plus lenalidomide (len) and dexamethasone (dex) is approved for... | ADMINISTERED THROUGHOUT THE TREATMENT PERIOD | DrugDosageText | CC BY | 32683487 | 19,057,439 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Empyema'. | Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
We report the first case of intraoperatively detected euglycemic diabetic ketoacidosis (DKA) associated with sodium-glucose cotransporter 2 inhibitors during thoracic surger... | EMPAGLIFLOZIN, INSULIN GLARGINE | DrugsGivenReaction | CC BY-NC-ND | 32686282 | 18,088,625 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Euglycaemic diabetic ketoacidosis'. | Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
We report the first case of intraoperatively detected euglycemic diabetic ketoacidosis (DKA) associated with sodium-glucose cotransporter 2 inhibitors during thoracic surger... | EMPAGLIFLOZIN, INSULIN GLARGINE | DrugsGivenReaction | CC BY-NC-ND | 32686282 | 18,088,625 | 2021-04 |
What is the weight of the patient? | Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
We report the first case of intraoperatively detected euglycemic diabetic ketoacidosis (DKA) associated with sodium-glucose cotransporter 2 inhibitors during thoracic surger... | 69 kg. | Weight | CC BY-NC-ND | 32686282 | 18,088,625 | 2021-04 |
What was the outcome of reaction 'Empyema'? | Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
We report the first case of intraoperatively detected euglycemic diabetic ketoacidosis (DKA) associated with sodium-glucose cotransporter 2 inhibitors during thoracic surger... | Recovering | ReactionOutcome | CC BY-NC-ND | 32686282 | 18,088,625 | 2021-04 |
What was the outcome of reaction 'Euglycaemic diabetic ketoacidosis'? | Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
We report the first case of intraoperatively detected euglycemic diabetic ketoacidosis (DKA) associated with sodium-glucose cotransporter 2 inhibitors during thoracic surger... | Recovered | ReactionOutcome | CC BY-NC-ND | 32686282 | 18,088,625 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Constipation'. | Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study.
OBJECTIVE
A refractory chronic migraine (RCM) accompanied by medication-overuse headache (MOH) is an extremely disabling disease. Evidence suggests that in selected patients, chronic opioids may be... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 32691178 | 18,727,749 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study.
OBJECTIVE
A refractory chronic migraine (RCM) accompanied by medication-overuse headache (MOH) is an extremely disabling disease. Evidence suggests that in selected patients, chronic opioids may be... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 32691178 | 18,722,654 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study.
OBJECTIVE
A refractory chronic migraine (RCM) accompanied by medication-overuse headache (MOH) is an extremely disabling disease. Evidence suggests that in selected patients, chronic opioids may be... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 32691178 | 18,722,657 | 2021-03 |
What was the outcome of reaction 'Constipation'? | Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study.
OBJECTIVE
A refractory chronic migraine (RCM) accompanied by medication-overuse headache (MOH) is an extremely disabling disease. Evidence suggests that in selected patients, chronic opioids may be... | Recovered | ReactionOutcome | CC BY | 32691178 | 18,727,749 | 2021-03 |
What was the outcome of reaction 'Nausea'? | Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study.
OBJECTIVE
A refractory chronic migraine (RCM) accompanied by medication-overuse headache (MOH) is an extremely disabling disease. Evidence suggests that in selected patients, chronic opioids may be... | Recovered | ReactionOutcome | CC BY | 32691178 | 18,722,654 | 2021-03 |
What was the outcome of reaction 'Vomiting'? | Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study.
OBJECTIVE
A refractory chronic migraine (RCM) accompanied by medication-overuse headache (MOH) is an extremely disabling disease. Evidence suggests that in selected patients, chronic opioids may be... | Recovered | ReactionOutcome | CC BY | 32691178 | 18,722,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | BEVACIZUMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 32715420 | 18,780,431 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastroenteritis'. | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | BEVACIZUMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 32715420 | 18,780,431 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal perforation'. | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | BEVACIZUMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 32715420 | 18,780,429 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | BEVACIZUMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 32715420 | 18,780,432 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudocirrhosis'. | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | BEVACIZUMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 32715420 | 18,780,432 | 2021-01 |
What was the outcome of reaction 'Cardiac failure'? | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | Fatal | ReactionOutcome | CC BY | 32715420 | 18,780,431 | 2021-01 |
What was the outcome of reaction 'Gastroenteritis'? | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | Fatal | ReactionOutcome | CC BY | 32715420 | 18,780,431 | 2021-01 |
What was the outcome of reaction 'Gastrointestinal perforation'? | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | Fatal | ReactionOutcome | CC BY | 32715420 | 18,780,429 | 2021-01 |
What was the outcome of reaction 'Hepatic failure'? | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | Fatal | ReactionOutcome | CC BY | 32715420 | 18,780,432 | 2021-01 |
What was the outcome of reaction 'Pseudocirrhosis'? | Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
OBJECTIVE
To investigate the effectiveness and safety of bevacizumab-paclitaxel combination therapy as first- or second-line chem... | Fatal | ReactionOutcome | CC BY | 32715420 | 18,780,432 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphopenia'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to liver'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial ischaemia'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pharyngeal abscess'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pharyngitis bacterial'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | MELPHALAN, PEGFILGRASTIM | DrugsGivenReaction | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the administration route of drug 'PEGFILGRASTIM'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | Subcutaneous | DrugAdministrationRoute | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the dosage of drug 'MELPHALAN'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | 3 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the dosage of drug 'PEGFILGRASTIM'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | 6 MILLIGRAM | DrugDosageText | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the outcome of reaction 'Death'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | Fatal | ReactionOutcome | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the outcome of reaction 'General physical health deterioration'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | Recovered | ReactionOutcome | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the outcome of reaction 'Myocardial ischaemia'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | Recovered | ReactionOutcome | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the outcome of reaction 'Pharyngeal abscess'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | Recovered | ReactionOutcome | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the outcome of reaction 'Pharyngitis bacterial'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | Recovered | ReactionOutcome | CC BY | 32761328 | 18,919,159 | 2021-02 |
What was the outcome of reaction 'Sepsis'? | Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
BACKGROUND
Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to... | Recovered | ReactionOutcome | CC BY | 32761328 | 18,919,159 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacterial sepsis'. | Hyper- and hypocoagulability in COVID-19 as assessed by thromboelastometry -two case reports.
Coronavirus disease (COVID-19)-associated coagulopathy is most often characterized by elevated D-dimer, interleukin-6, and plasma fibrinogen concentrations as well as hypercoagulability in thromboelastometry with increased clo... | CEFTRIAXONE, DOXYCYCLINE, NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC | 32773727 | 20,408,037 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Hyper- and hypocoagulability in COVID-19 as assessed by thromboelastometry -two case reports.
Coronavirus disease (COVID-19)-associated coagulopathy is most often characterized by elevated D-dimer, interleukin-6, and plasma fibrinogen concentrations as well as hypercoagulability in thromboelastometry with increased clo... | CEFTRIAXONE, DOXYCYCLINE, NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC | 32773727 | 20,408,037 | 2021-08 |
What was the outcome of reaction 'Condition aggravated'? | Hyper- and hypocoagulability in COVID-19 as assessed by thromboelastometry -two case reports.
Coronavirus disease (COVID-19)-associated coagulopathy is most often characterized by elevated D-dimer, interleukin-6, and plasma fibrinogen concentrations as well as hypercoagulability in thromboelastometry with increased clo... | Fatal | ReactionOutcome | CC BY-NC | 32773727 | 20,408,037 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Case reports of hypercalcemia and chronic renal disease due to cosmetic injections of polymethylmethacrylate (PMMA).
Cosmetic injections of fillers are common plastic surgery procedures worldwide. Polymethylmethacrylate (PMMA) is a filler approved only for minimally invasive procedures in facial tissue and is among the... | PREDNISONE | DrugsGivenReaction | CC BY | 32779690 | 19,967,040 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Case reports of hypercalcemia and chronic renal disease due to cosmetic injections of polymethylmethacrylate (PMMA).
Cosmetic injections of fillers are common plastic surgery procedures worldwide. Polymethylmethacrylate (PMMA) is a filler approved only for minimally invasive procedures in facial tissue and is among the... | PREDNISONE | DrugsGivenReaction | CC BY | 32779690 | 19,967,040 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
Stiff Person Syndrome (SPS) is a rare immune-mediated disabling neurological disorder characterised by muscle spasms and high GAD antibodies. There are only a few case reports of autologous haematopoietic stem c... | IMMUNE GLOBULIN NOS, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 32785838 | 19,728,152 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis B core antigen positive'. | Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
Stiff Person Syndrome (SPS) is a rare immune-mediated disabling neurological disorder characterised by muscle spasms and high GAD antibodies. There are only a few case reports of autologous haematopoietic stem c... | HUMAN IMMUNOGLOBULIN G, RITUXIMAB | DrugsGivenReaction | CC BY | 32785838 | 19,779,285 | 2021-01 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
Stiff Person Syndrome (SPS) is a rare immune-mediated disabling neurological disorder characterised by muscle spasms and high GAD antibodies. There are only a few case reports of autologous haematopoietic stem c... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32785838 | 19,779,285 | 2021-01 |
What was the administration route of drug 'IMMUNE GLOBULIN NOS'? | Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
Stiff Person Syndrome (SPS) is a rare immune-mediated disabling neurological disorder characterised by muscle spasms and high GAD antibodies. There are only a few case reports of autologous haematopoietic stem c... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32785838 | 19,729,244 | 2021-01 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
Stiff Person Syndrome (SPS) is a rare immune-mediated disabling neurological disorder characterised by muscle spasms and high GAD antibodies. There are only a few case reports of autologous haematopoietic stem c... | UNK UNK, QOW | DrugDosageText | CC BY | 32785838 | 19,779,285 | 2021-01 |
What was the dosage of drug 'RITUXIMAB'? | Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
Stiff Person Syndrome (SPS) is a rare immune-mediated disabling neurological disorder characterised by muscle spasms and high GAD antibodies. There are only a few case reports of autologous haematopoietic stem c... | SHE HAD RECEIVED THREE INFUSIONS OF RITUXIMAB | DrugDosageText | CC BY | 32785838 | 19,729,213 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Portal vein thrombosis'. | Portal Vein Thrombosis in Metastatic Colorectal Cancer During FOLFIRI-bevacizumab Chemotherapy Successfully Treated with Apixaban.
Portal vein thrombosis (PVT) while using an angiogenesis inhibitor is relatively rare. A 70-year-old Asian man was diagnosed with PVT two months after initiating 5-fluorouracil/leucovorin, ... | BEVACIZUMAB, FLUOROURACIL, IRINOTECAN, LEUCOVORIN | DrugsGivenReaction | CC BY-NC-ND | 32788527 | 18,923,636 | 2021-01-01 |
What was the outcome of reaction 'Portal vein thrombosis'? | Portal Vein Thrombosis in Metastatic Colorectal Cancer During FOLFIRI-bevacizumab Chemotherapy Successfully Treated with Apixaban.
Portal vein thrombosis (PVT) while using an angiogenesis inhibitor is relatively rare. A 70-year-old Asian man was diagnosed with PVT two months after initiating 5-fluorouracil/leucovorin, ... | Recovered | ReactionOutcome | CC BY-NC-ND | 32788527 | 18,923,636 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angle closure glaucoma'. | Acute angle-closure glaucoma and effusion syndrome after phacoemulsification.
A 72-year-old female patient developed bilateral secondary iridocorneal angle-closure glaucoma with uveal effusion syndrome after uncomplicated cataract surgery. The postoperative intake of acetazolamide was identified as causative for the de... | ACETAZOLAMIDE, APRACLONIDINE HYDROCHLORIDE, TIMOLOL | DrugsGivenReaction | CC BY | 32803274 | 18,639,253 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Choroidal effusion'. | Acute angle-closure glaucoma and effusion syndrome after phacoemulsification.
A 72-year-old female patient developed bilateral secondary iridocorneal angle-closure glaucoma with uveal effusion syndrome after uncomplicated cataract surgery. The postoperative intake of acetazolamide was identified as causative for the de... | ACETAZOLAMIDE, APRACLONIDINE HYDROCHLORIDE, TIMOLOL | DrugsGivenReaction | CC BY | 32803274 | 18,639,253 | 2021-08 |
What was the administration route of drug 'ACETAZOLAMIDE'? | Acute angle-closure glaucoma and effusion syndrome after phacoemulsification.
A 72-year-old female patient developed bilateral secondary iridocorneal angle-closure glaucoma with uveal effusion syndrome after uncomplicated cataract surgery. The postoperative intake of acetazolamide was identified as causative for the de... | Oral | DrugAdministrationRoute | CC BY | 32803274 | 18,639,253 | 2021-08 |
What was the administration route of drug 'APRACLONIDINE HYDROCHLORIDE'? | Acute angle-closure glaucoma and effusion syndrome after phacoemulsification.
A 72-year-old female patient developed bilateral secondary iridocorneal angle-closure glaucoma with uveal effusion syndrome after uncomplicated cataract surgery. The postoperative intake of acetazolamide was identified as causative for the de... | Topical | DrugAdministrationRoute | CC BY | 32803274 | 18,639,253 | 2021-08 |
What was the administration route of drug 'TIMOLOL'? | Acute angle-closure glaucoma and effusion syndrome after phacoemulsification.
A 72-year-old female patient developed bilateral secondary iridocorneal angle-closure glaucoma with uveal effusion syndrome after uncomplicated cataract surgery. The postoperative intake of acetazolamide was identified as causative for the de... | Topical | DrugAdministrationRoute | CC BY | 32803274 | 18,639,253 | 2021-08 |
What was the outcome of reaction 'Angle closure glaucoma'? | Acute angle-closure glaucoma and effusion syndrome after phacoemulsification.
A 72-year-old female patient developed bilateral secondary iridocorneal angle-closure glaucoma with uveal effusion syndrome after uncomplicated cataract surgery. The postoperative intake of acetazolamide was identified as causative for the de... | Recovered | ReactionOutcome | CC BY | 32803274 | 18,639,253 | 2021-08 |
What was the outcome of reaction 'Choroidal effusion'? | Acute angle-closure glaucoma and effusion syndrome after phacoemulsification.
A 72-year-old female patient developed bilateral secondary iridocorneal angle-closure glaucoma with uveal effusion syndrome after uncomplicated cataract surgery. The postoperative intake of acetazolamide was identified as causative for the de... | Recovered | ReactionOutcome | CC BY | 32803274 | 18,639,253 | 2021-08 |
What was the administration route of drug 'DULOXETINE'? | Managing dissociative symptoms following the use of esketamine nasal spray: a case report.
Patients with treatment-resistant depression (TRD) treated with esketamine nasal spray commonly experience transient symptoms of dissociation. Manifestations of dissociation, such as feelings of detachment from the environment, c... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32804743 | 20,363,624 | 2021-01 |
What was the administration route of drug 'ESKETAMINE'? | Managing dissociative symptoms following the use of esketamine nasal spray: a case report.
Patients with treatment-resistant depression (TRD) treated with esketamine nasal spray commonly experience transient symptoms of dissociation. Manifestations of dissociation, such as feelings of detachment from the environment, c... | Nasal | DrugAdministrationRoute | CC BY-NC-ND | 32804743 | 20,363,624 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colorectal cancer'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | INFLIXIMAB | DrugsGivenReaction | CC BY-NC | 32806874 | 18,243,187 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | INFLIXIMAB | DrugsGivenReaction | CC BY-NC | 32806874 | 18,243,194 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis psoriasiform'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug specific antibody present'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypersensitivity'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infusion related reaction'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Laboratory test abnormal'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lower respiratory tract infection'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphoma'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | INFLIXIMAB | DrugsGivenReaction | CC BY-NC | 32806874 | 18,243,206 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Musculoskeletal disorder'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervous system disorder'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostate cancer'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | INFLIXIMAB | DrugsGivenReaction | CC BY-NC | 32806874 | 18,243,189 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psoriasis'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychiatric symptom'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory tract infection'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin infection'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin reaction'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thyroid cancer'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | INFLIXIMAB | DrugsGivenReaction | CC BY-NC | 32806874 | 18,243,199 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | AZATHIOPRINE, INFLIXIMAB, METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32806874 | 16,626,515 | 2021-10 |
What was the administration route of drug 'INFLIXIMAB'? | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 32806874 | 18,243,194 | 2021-10 |
What was the outcome of reaction 'Colorectal cancer'? | Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
OBJECTIVE
The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment. However, the association betwee... | Fatal | ReactionOutcome | CC BY-NC | 32806874 | 18,243,195 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | AZILSARTAN KAMEDOXOMIL, BISOPROLOL, BROMFENAC SODIUM, CALCIUM GLUCONATE, CARTEOLOL HYDROCHLORIDE, DEXTROSE, DORZOLAMIDE HYDROCHLORIDE, DOXAZOSIN MESYLATE, EDOXABAN TOSYLATE, HEPARIN SODIUM, INSULIN NOS, LANDIOLOL HYDROCHLORIDE, REBAMIPIDE, TRAVOPROST, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus node dysfunction'. | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | AZILSARTAN KAMEDOXOMIL, BISOPROLOL, BROMFENAC SODIUM, CALCIUM GLUCONATE, CARTEOLOL HYDROCHLORIDE, DEXTROSE, DORZOLAMIDE HYDROCHLORIDE, DOXAZOSIN MESYLATE, EDOXABAN TOSYLATE, HEPARIN SODIUM, INSULIN NOS, LANDIOLOL HYDROCHLORIDE, REBAMIPIDE, TRAVOPROST, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
What was the administration route of drug 'AZILSARTAN KAMEDOXOMIL'? | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Ophthalmic carteolol is often used to treat glaucoma. Elderly patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are common among the super-el... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32830185 | 18,270,051 | 2021-01-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.